IOL correcting presbyopia exposed to AAO

Johnson & Johnson Vision today announced the availability of Tecnis Symfony OptiBlue IOL. its presbyopia-correcting intraocular lens (PC-IOL) powered by InteliLight technology.

This Extended Depth of Field (EDOF) lens extends presbyopia correction to more patients and joins Tecnis Synergy IOL, a high-performance hybrid lens designed for spectacle independence****, in the InteliLight lineup . These two complementary products offer contrast and low-light performance in the PC-IOL category.1,2,3 The InteliLight portfolio will be showcased at the 2022 American Academy of Ophthalmology Annual Meeting in Chicago.

Cataracts are the leading cause of preventable blindness worldwide, affecting more than 100 million eyes worldwide.1,2 Cataracts are a clouding of the lens of the eye, caused by a buildup of the eye’s natural proteins that alter the way the eye focuses light, thereby altering the color and clarity of vision.3 Most people will develop cataracts at some point in their lives, but cataracts can be treated with surgery. modern cataract surgery is a safe and effective treatment that has a success rate of almost 98%.4

“My goal as an eye care professional is to provide the best results for my patients and help them resume some of the activities many of us take for granted – driving at night, walking up and down stairs at home. in dim light, or simply go out at night and dine out, all with less risk”5 said Karolinne Rocha, MD, PhD, MUSC/Storm Eye Institute, Charleston, SC “In my practice, we have seen TECNIS Symfony OptiBlue IOL provide good image contrast day and night, at all distances. Best of all, it has a minimized dysphotopsia profile which gives me the comfort I need to recommend presbyopia correction to more patients.”

Tecnis Symfony OptiBlue IOL is powered by InteliLight, an innovative combination of three Johnson & Johnson Vision proprietary technologies: violet light filter, ladder design and achromatic technology. The technology was first introduced in the Tecnis Synergy IOL.

  • Violet light filter: Blocks the shortest wavelengths of light that produce the most light scattering,6,7,8 helping to reduce halo, glare and starbursts,9,10,11, and minimize visual disturbances when driving at night.11
  • Ladder design: Helps reduce light scatter and halo intensity,9.12 making it easier to view digital devices.10.11

Achromatic technology: Corrects chromatic aberration for better contrast day or night8.11 and superior performance over all distances.2.3

“We know that our patients’ lives don’t end when the sun goes down, and neither should their confidence in their ability to see clearly or drive at night,” said Nikki Sidi, vice president, Global Strategic Marketing, Surgical Vision, Johnson & Johnson Vision. “The InteliLight PCIOL portfolio delivers best-in-class contrast and low-light performance*.1,2,3 And with Tecnis Synergy for spectacle independence and TECNIS SymfonyOptiBlue for functional vision at all distances, surgeons can now choose the best low-light performing PCIOL based on their patient’s needs.

The Tecnis PC-IOL portfolio powered by InteliLight is now available to ophthalmologists in the US and select EMEA countries. Portfolio lenses, TECNIS Synergy IOL and TECNIS Symfony OptiBlue IOL, are also available in Toric II for excellent rotational stability1 for astigmatic patients.


1 DOF2021CT4019 – TECNIS™ Toric II IOL Rotational Stability Clinical Study – Steele Study NXGT-202-QROS. August 20, 2021.

2 World Health Organization – Priority eye diseases. REF 2016 OTHER 0004.

3 World Health Organization. Blindness and impairment.

4 American Optometric Association. Cataract. Accessed May 24, 2022.

5 Vision Health Initiative, Common Eye Disorders. Centers for Control and Prevention of Disasters.

6 Szanton SL, Walker RK, Roberts L, Thorpe RJ, Jr., Wolff J et al. 2015. Older people’s favorite activities are extremely active: Findings from the NHATS study. Geriatric nurses 36 (2): 131-135.

7 ARVO 2020_Effect of blocking violet light in extended depth of field IOL: SC2019CT4056.

8 Mainster MA. Anti-blue intraocular lenses: myth or reality? Am J Ophthalmol. 2009;1:8-10. REF2014CT0140 Blocks the shortest wavelengths (p.1).

9 ARVO 2019_Optical and Visual Performance of Violet Blocking IOL: SC2019CT4025

10 Effect of violet light blocking in EDOF IOLs. JNJ ArvoAbstractMay 2020/Optical and visual performance of SC2019CT4025 violet-blocking IOL.

11 DOF2020CT4011: DOF Effect of Violet Light Blocking on Light Scattering in Tecnis Symfony™ IOLs (v1.0).

12 InteliLight USA Sales Support. PP2022MLT5751

Comments are closed.